In recent literature, the rates for GI bleeds have been noted to be highest for patients on rivaroxaban and lowest for patients on apixaban
NAC is actually a precursor to glutathione, and it has recently been proven highly efficient at treating neurocognitive issues like addiction, compulsive behaviors, schizophrenia and bipolar disorder
This article explores the mechanisms behind Wegovy's action, identifies common barriers to weight loss, and provides evidence-based strategies to optimise your treatment outcomes whilst maintaining realistic expectations about this GLP-1 receptor agonist therapy
Followed by weekly, then monthly maintenance doses
Regular follow-up appointments allow for assessment of weight loss progress, management of side effects, and evaluation of whether continued treatment remains clinically appropriate within NHS prescribing frameworks